Amgen Inc. Investing Cash Flow
Amgen Inc. (AMGN) reported Investing Cash Flow of -$1.28 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- Amgen Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$569.00M.
- Amgen Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$716.00M.
- Amgen Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$693.00M.
- Amgen Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$414.00M.
- Amgen Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$1.94B.
- Amgen Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$1.05B.
- Amgen Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$26.20B.
- Amgen Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$6.04B, a 924.56% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$569.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.28B 10-Q · filed 2026-08-05 | -$1.98B derived: sum of 3 quarters · filed 2026-08-05 | -$2.39B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$716.00M 10-Q · filed 2026-05-01 | -$1.41B derived: sum of 2 quarters · filed 2026-05-01 | -$1.82B derived: sum of 3 quarters · filed 2026-05-01 | -$2.21B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$693.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.11B derived: sum of 2 quarters · filed 2026-02-13 | -$1.50B derived: sum of 3 quarters · filed 2026-08-05 | -$1.94B 10-K · filed 2026-02-13 |
| 2025-09-30 | -$414.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$803.00M derived: sum of 2 quarters · filed 2026-08-05 | -$1.25B 10-Q · filed 2025-11-05 | -$1.65B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$389.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$836.00M 10-Q · filed 2026-08-05 | -$1.24B derived: sum of 3 quarters · filed 2026-08-05 | -$1.45B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$447.00M 10-Q · filed 2026-05-01 | -$849.00M derived: sum of 2 quarters · filed 2026-05-01 | -$1.06B derived: sum of 3 quarters · filed 2026-05-01 | -$1.28B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$402.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$612.00M derived: sum of 2 quarters · filed 2026-02-13 | -$829.00M derived: sum of 3 quarters · filed 2026-02-13 | -$1.05B 10-K · filed 2026-02-13 |
| 2024-09-30 | -$210.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$427.00M derived: sum of 2 quarters · filed 2025-11-05 | -$644.00M 10-Q · filed 2025-11-05 | -$27.73B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$217.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$434.00M 10-Q · filed 2025-08-06 | -$27.52B derived: sum of 3 quarters · filed 2026-02-13 | -$27.79B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$217.00M 10-Q · filed 2025-05-02 | -$27.31B derived: sum of 2 quarters · filed 2026-02-13 | -$27.57B derived: sum of 3 quarters · filed 2026-02-13 | -$27.78B derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$27.09B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$27.35B derived: sum of 2 quarters · filed 2026-02-13 | -$27.56B derived: sum of 3 quarters · filed 2026-02-13 | -$26.20B 10-K · filed 2026-02-13 |
| 2023-09-30 | -$262.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$473.00M derived: sum of 2 quarters · filed 2024-10-31 | $885.00M 10-Q · filed 2024-10-31 | -$2.59B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | -$211.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.15B 10-Q · filed 2024-08-07 | -$2.33B derived: sum of 3 quarters · filed 2025-02-14 | -$2.59B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $1.36B 10-Q · filed 2024-05-03 | -$2.12B derived: sum of 2 quarters · filed 2025-02-14 | -$2.38B derived: sum of 3 quarters · filed 2025-02-14 | -$4.58B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | -$3.47B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$3.74B derived: sum of 2 quarters · filed 2025-02-14 | -$5.93B derived: sum of 3 quarters · filed 2025-02-14 | -$6.04B 10-K · filed 2025-02-14 |
| 2022-09-30 | -$267.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$2.46B derived: sum of 2 quarters · filed 2023-10-31 | -$2.57B 10-Q · filed 2023-10-31 | -$2.80B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$2.19B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.30B 10-Q · filed 2023-08-04 | -$2.53B derived: sum of 3 quarters · filed 2024-02-14 | -$2.46B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$111.00M 10-Q · filed 2023-04-28 | -$341.00M derived: sum of 2 quarters · filed 2024-02-14 | -$268.00M derived: sum of 3 quarters · filed 2024-02-14 | $941.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$230.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$157.00M derived: sum of 2 quarters · filed 2024-02-14 | $1.05B derived: sum of 3 quarters · filed 2024-02-14 | $733.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.28B derived: sum of 2 quarters · filed 2022-11-04 | $963.00M 10-Q · filed 2022-11-04 | -$421.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $1.21B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $890.00M 10-Q · filed 2022-08-05 | -$494.00M derived: sum of 3 quarters · filed 2023-02-09 | -$2.12B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | -$319.00M 10-Q · filed 2022-04-28 | -$1.70B derived: sum of 2 quarters · filed 2023-02-09 | -$3.33B derived: sum of 3 quarters · filed 2023-02-09 | -$5.49B derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | -$1.38B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$3.01B derived: sum of 2 quarters · filed 2023-02-09 | -$5.17B derived: sum of 3 quarters · filed 2023-02-09 | -$5.40B 10-K · filed 2023-02-09 |
| 2020-09-30 | -$1.63B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$3.79B derived: sum of 2 quarters · filed 2021-11-03 | -$4.02B 10-Q · filed 2021-11-03 | -$9.98B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$2.16B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$2.39B 10-Q · filed 2021-08-04 | -$8.35B derived: sum of 3 quarters · filed 2022-02-16 | -$2.98B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$230.00M 10-Q · filed 2021-04-28 | -$6.19B derived: sum of 2 quarters · filed 2022-02-16 | -$821.00M derived: sum of 3 quarters · filed 2022-02-16 | $1.92B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$5.96B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$591.00M derived: sum of 2 quarters · filed 2022-02-16 | $2.15B derived: sum of 3 quarters · filed 2022-02-16 | $5.71B 10-K · filed 2022-02-16 |
| 2019-09-30 | $5.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $8.12B derived: sum of 2 quarters · filed 2020-10-29 | $11.67B 10-Q · filed 2020-10-29 | $7.04B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $2.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $6.30B 10-Q · filed 2020-07-29 | $1.66B derived: sum of 3 quarters · filed 2021-02-09 | $2.79B derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $3.56B 10-Q · filed 2020-05-01 | -$1.08B derived: sum of 2 quarters · filed 2021-02-09 | $50.00M derived: sum of 3 quarters · filed 2021-02-09 | $2.99B derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$4.64B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$3.50B derived: sum of 2 quarters · filed 2021-02-09 | -$567.00M derived: sum of 3 quarters · filed 2021-02-09 | $14.34B 10-K · filed 2021-02-09 |
| 2018-09-30 | $1.13B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $4.07B derived: sum of 2 quarters · filed 2019-10-30 | $18.98B 10-Q · filed 2019-10-30 | $18.90B derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $2.94B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $17.84B 10-Q · filed 2019-07-31 | $17.77B derived: sum of 3 quarters · filed 2020-02-12 | $15.79B derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $14.91B 10-Q · filed 2019-05-01 | $14.83B derived: sum of 2 quarters · filed 2020-02-12 | $12.85B derived: sum of 3 quarters · filed 2020-02-12 | $11.04B derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | -$78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$2.05B derived: sum of 2 quarters · filed 2020-02-12 | -$3.87B derived: sum of 3 quarters · filed 2020-02-12 | -$4.02B 10-K · filed 2020-02-12 |
| 2017-09-30 | -$1.98B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$3.79B derived: sum of 2 quarters · filed 2018-10-31 | -$3.95B 10-Q · filed 2018-10-31 | -$5.17B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | -$1.81B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$1.97B 10-Q · filed 2018-07-27 | -$3.19B derived: sum of 3 quarters · filed 2019-02-13 | -$5.58B derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | -$157.00M 10-Q · filed 2018-04-25 | -$1.38B derived: sum of 2 quarters · filed 2019-02-13 | -$3.77B derived: sum of 3 quarters · filed 2019-02-13 | -$4.42B derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | -$1.22B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$3.61B derived: sum of 2 quarters · filed 2019-02-13 | -$4.27B derived: sum of 3 quarters · filed 2019-02-13 | -$8.66B 10-K · filed 2019-02-13 |
| 2016-09-30 | -$2.39B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$3.05B derived: sum of 2 quarters · filed 2017-10-26 | -$7.44B 10-Q · filed 2017-10-26 | -$7.67B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$657.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$5.05B 10-Q · filed 2017-07-26 | -$5.28B derived: sum of 3 quarters · filed 2018-02-13 | -$7.28B derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | -$4.39B 10-Q · filed 2017-04-27 | -$4.62B derived: sum of 2 quarters · filed 2018-02-13 | -$6.63B derived: sum of 3 quarters · filed 2018-02-13 | -$8.98B derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | -$233.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$2.24B derived: sum of 2 quarters · filed 2018-02-13 | -$4.59B derived: sum of 3 quarters · filed 2018-02-13 | -$5.55B 10-K · filed 2018-02-13 |
| 2015-09-30 | -$2.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$4.36B derived: sum of 2 quarters · filed 2016-10-28 | -$5.31B 10-Q · filed 2016-10-28 | -$4.94B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | -$2.36B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$3.31B 10-Q · filed 2016-07-29 | -$2.94B derived: sum of 3 quarters · filed 2017-02-14 | -$5.84B derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | -$952.00M 10-Q · filed 2016-05-02 | -$578.00M derived: sum of 2 quarters · filed 2017-02-14 | -$3.48B derived: sum of 3 quarters · filed 2017-02-14 | -$5.94B derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $374.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$2.53B derived: sum of 2 quarters · filed 2017-02-14 | -$4.99B derived: sum of 3 quarters · filed 2017-02-14 | -$5.75B 10-K · filed 2017-02-14 |
| 2014-09-30 | -$2.90B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$5.36B derived: sum of 2 quarters · filed 2015-11-02 | -$6.13B 10-Q · filed 2015-11-02 | -$16.24B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | -$2.46B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$3.22B 10-Q · filed 2015-08-05 | -$13.34B derived: sum of 3 quarters · filed 2016-10-31 | -$15.46B derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | -$765.00M 10-Q · filed 2015-04-27 | -$10.88B derived: sum of 2 quarters · filed 2016-10-31 | -$13.00B derived: sum of 3 quarters · filed 2016-10-31 | -$11.04B derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | -$10.12B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | -$12.24B derived: sum of 2 quarters · filed 2016-10-31 | -$10.28B derived: sum of 3 quarters · filed 2016-10-31 | -$8.47B 8-K · filed 2016-10-31 |
| 2013-09-30 | -$2.12B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$160.00M derived: sum of 2 quarters · filed 2014-10-29 | $1.65B 10-Q · filed 2014-10-29 | -$382.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $1.96B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $3.77B 10-Q · filed 2014-08-05 | $1.74B derived: sum of 3 quarters · filed 2015-02-19 | -$1.44B derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $1.81B 10-Q · filed 2014-04-30 | -$222.00M derived: sum of 2 quarters · filed 2015-02-19 | -$3.40B derived: sum of 3 quarters · filed 2015-02-19 | -$5.83B derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | -$2.03B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | -$5.20B derived: sum of 2 quarters · filed 2015-02-19 | -$7.64B derived: sum of 3 quarters · filed 2015-02-19 | -$9.99B 10-K · filed 2015-02-19 |
| 2012-09-30 | -$3.17B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$5.61B derived: sum of 2 quarters · filed 2013-10-29 | -$7.96B 10-Q · filed 2013-10-29 | -$8.18B derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | -$2.44B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$4.79B 10-Q · filed 2013-08-06 | -$5.01B derived: sum of 3 quarters · filed 2014-02-24 | -$5.86B derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | -$2.35B 10-Q · filed 2013-05-03 | -$2.57B derived: sum of 2 quarters · filed 2014-02-24 | -$3.42B derived: sum of 3 quarters · filed 2014-02-24 | -$2.58B derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | -$220.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$1.08B derived: sum of 2 quarters · filed 2014-02-24 | -$231.00M derived: sum of 3 quarters · filed 2014-02-24 | -$786.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | -$857.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$11.00M derived: sum of 2 quarters · filed 2012-11-06 | -$566.00M 10-Q · filed 2012-11-06 | -$1.06B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $846.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $291.00M 10-Q · filed 2012-08-08 | -$200.00M derived: sum of 3 quarters · filed 2013-02-27 | -$1.47B derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | -$555.00M 10-Q · filed 2012-05-08 | -$1.05B derived: sum of 2 quarters · filed 2013-02-27 | -$2.32B derived: sum of 3 quarters · filed 2013-02-27 | -$3.75B derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | -$491.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$1.76B derived: sum of 2 quarters · filed 2013-02-27 | -$3.20B derived: sum of 3 quarters · filed 2013-02-27 | -$4.15B 10-K · filed 2013-02-27 |
| 2010-09-30 | -$1.27B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.71B derived: sum of 2 quarters · filed 2011-11-04 | -$3.66B 10-Q · filed 2011-11-04 | -$4.00B derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | -$1.44B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$2.39B 10-Q · filed 2011-08-08 | -$2.73B derived: sum of 3 quarters · filed 2012-02-29 | -$4.15B derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | -$955.00M 10-Q · filed 2011-05-10 | -$1.29B derived: sum of 2 quarters · filed 2012-02-29 | -$2.71B derived: sum of 3 quarters · filed 2012-02-29 | -$4.30B derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | -$339.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$1.76B derived: sum of 2 quarters · filed 2012-02-29 | -$3.34B derived: sum of 3 quarters · filed 2012-02-29 | -$3.20B 10-K · filed 2012-02-29 |
| 2009-09-30 | -$1.42B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$3.00B derived: sum of 2 quarters · filed 2010-11-08 | -$2.86B 10-Q · filed 2010-11-08 | -$3.41B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | -$1.58B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | -$1.44B 10-Q · filed 2010-08-09 | -$1.99B derived: sum of 3 quarters · filed 2011-02-25 | -$4.31B derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $139.00M 10-Q · filed 2010-05-07 | -$408.00M derived: sum of 2 quarters · filed 2011-02-25 | -$2.73B derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$547.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$2.87B derived: sum of 2 quarters · filed 2011-02-25 | -$3.17B 10-K · filed 2011-02-25 | |
| 2008-09-30 | -$2.33B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | -$2.62B 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | -$293.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | -$1.99B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |